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ABSTRACT
Protein-protein interactions are vital in maintaining proper function and
homeostasis in cells. Some signaling pathways are regulated by G-proteins that work like
switches to activate and deactivate pathways. Mutations in these proteins, their effectors
or the interaction between proteins may cause dysregulation of signals that can lead to
many diseases.
Rheb, Ras homology enriched in brain, is a Ras family GTPase that is vital in
regulation of the mTOR (mammalian target of rapamycin) pathway that signals cell
proliferation and growth. Due to the low intrinsic GTPase activity of Rheb, a GTPase
activating protein (GAP), Tuberous Sclerosis Complex 2 (TSC2) down regulates Rheb by
enhancing its GTPase activity. Currently, very little information is available about TSC2
structures and the molecular details of the interaction between the two proteins. We
explored various biochemical and biophysical information of Rheb-TSC2 interaction. In
addition, we characterized the stability of the variant, TSC2-218 (D74A), using a 218
amino acid truncated construct of TSC2, and the effects of the single point mutation on
the interactions with Rheb. In comparison to the WT, the D74A variant showed to
maintain protein stability (thermal and chemical), an increase in secondary (alpha helical)
structure, binding and GAP activity towards Rheb.
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I.

Chapter 1: Introduction

1.1 mTOR, Ras, GEF and GAP
Protein-protein interaction and signaling are the basis for many biochemical processes in
cells. To maintain proper function of metabolic activity, signaling pathways are often regulated
by proteins. Any dysregulation of the pathways can lead to improper downstream activity and
disease states.
Ras superfamily of G-proteins are a class of highly conserved GTPases that act as
switches in various signaling pathways by cycling nucleotides to activate or deactivate the
pathways (1). When the protein is bound to GTP (guanosine triphosphate), the protein is
biologically active; whereas, when bound to GDP (guanosine diphosphate), the protein is
inactive (1).
GTPases are able to intrinsically hydrolyze GTP (active) to GDP (inactive) + Pi
(inorganic phosphate). Therefore, GTPases interact with effectors (guanine exchange factors and
GTPase activating proteins) that enable nucleotide cycling and hydrolysis (Figure 1).

Figure 1. Schematic of GTPase protein cycling between active (GTP-bound) and inactive (GDPbound) states and the roles of guanine exchange factors (GEFs) and GTPase activating proteins
(GAPs). Schematic was designed in Google Slides.
1

Guanine exchange factors (GEFs) bind to GDP-bound GTPase and stimulate the release
of GDP, thus allowing the attachment of GTP (found in high concentrations in the cell). This
establishes the protein to switch from an inactive to active state and furthers the signal
downstream. When the biologically active protein is no longer required, GTP hydrolysis
necessary to turn the signal off. This is accomplished by effectors known at GTPase activating
proteins (GAPs). GAPs bind to GTPase proteins (GTP-bound and active) and promote GTP
hydrolysis to GDP + Pi; thus, the protein is no longer active and the signal downstream is halted.
Small GTPases from the Ras superfamily, specifically Rheb and Rag, are commonly
known to regulate mTOR pathway (39). The mTOR, mammalian target of rapamycin, pathway is
a vital signaling pathway which regulates cell growth and proliferation by promoting protein,
lipids and nucleic acid synthesis (3). mTOR is a serine/threonine kinase that is comprised of 2
functionally different complexes; mTOR complex 1 (mTORC1) and mTOR complex 2
(mTORC2). mTORC1 (referred to as Raptor) is sensitive to rapamycin, whereas, mTORC2 is
(referred to as Rictor) is resistant to rapamycin (4) (5) (6). Both mTORC1 and mTORC2 act as
scaffolding proteins and they recruit and interact with many regulatory proteins. While mTORC1
functions in protein synthesis via S6K and 4EBP1, mTORC2 centers on phosphorylation of Akt
in presence of insulin (7).
Normally, the kinase activity of mTORC1 and mTORC2 towards 4E-BP1 and Akt,
respectively, are minimal (7). Active Rheb enhances kinase activity of mTORC1, and thus,
increases the amount of phosphorylated 4E-BP1 (substrate of raptor/ mTORC1) in vitro (7) (8).
However, Rheb does not augment kinase activity in mTORC2 toward Akt (7) (8). Within the Ras
family, Rheb, unlike K-Ras, RalA, RalB and Rad proteins, was the only g-protein to exhibit
mTORC1 activation (7). In addition, Rho family small G-proteins were also unable to activate
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mTORC1 (7). Due to the importance of the mTOR pathway in maintaining homeostasis,
dysregulation of signaling can cause various human diseases such as cancers, obesity, diabetes
(9) (10).
1.2 Rheb
Rheb, Ras homology enriched in brain, is a small 20kDa GTPase in the Ras superfamily
of GTPases that was first identified in neural tissues primarily in the brain (11).
Many sequences of Rheb are homologous (about 30-45% sequence) with other small
GTPases, primarily Ras/Rap subfamily (11). The 5 regions, G1-G5 which are specific to GTP
binding, contain the highest homology between Rheb and its corresponding Ras family proteins
(11). Structural comparisons also confirm that Rheb is most closely related to the Ras and R
family than RhoA and Rab5A (12).
Rheb and other small GTPases have 3 main regions: Switch I (residues 33-41), Switch II
(residues 63-79) and P loop, each with distinct characteristics (12) (13) (14). Switch I of small
GTPases are vital in identifying and interacting with their effectors; therefore, any variation in
primary sequences and/or structures of the Switch I region contributes to the specificity of small
GTPases to the corresponding effectors (12). The Switch I sequence of Rheb has high flexibility,
like that of other GTPases (most similar to Ras and Rap). Structural comparison of the Switch I
region also confirmed higher similarity to Ras and Rap than Rho and Rab, in respect to
complexes with nucleotides (GDP, GTP, GTP analog) (12).
The Switch II region displays major differences between small GTPases and Rheb (12).
Typically, the Switch II region of small GTPases have an alpha helical conformation when
complexed with GTP (or GTP analog), but assume a slightly disordered conformation at the Nterminal when complexed with GDP (15). In the process of GTP and GDP cycling, this Switch II
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region undergoes a drastic conformational change in most GTPases. In contrast, in GTP-bound
Rheb, the Switch II region is in an unraveled conformation rather than the typical alpha helical
conformation as seen in GTPases. Hydrophobic and hydrophilic interactions between key
residues in the N-terminal and C-terminal of the Switch II region appear to stabilize the
conformation in Rheb (12). Interestingly, Yu et. al. found that the Switch II region of Rheb
undergoes minimal conformational changes while cycling between GTP and GDP. Also, Switch
II residue Gln64 is slightly displaced compared to the corresponding Ras (Gln61) and Rap
(Thr61) residues (12). In addition, they found that this polar side chain is positioned away from
the GTP-binding site and buried in a hydrophobic pocket (12). This leads to a lack of interaction
with GTP, water molecules or nearby catalytic site residues. Further, Ras proteins normally
contain a conserved Gly12 in the P loop; in contrast, Rheb has an arginine (R15) and serine
(S16) that bind to GDP or GTP (13) (16) (17). The distinct and stable conformormation of Rheb,
the inability of residue Gln64 to participate in GTP hydrolysis (unlike Ras counterpart, Gln61)
and arginine and serine in lieu of glycine in the P loop, are thought to be the primary reasons for
Rheb’s low intrinsic GTPase activity.
Data has consistently shown that Rheb has a low intrinsic GTPase activity, which is
uncharacteristic of most GTPases, and is found in a constitutively active (GTP-bound) state (18)
(19). Therefore, there is a vital need for down regulation of Rheb via protein-protein interaction
to prevent consequences of overactive signaling of the mTOR pathway. This is achieved by
TSC1-TSC2 complex which acts as a GTPase-activating protein for Rheb and enhances Rheb’s
ability to undergo GTP hydrolysis in order to return to an inactive GDP-bound state (20) (21)
(22) (23) (24).
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1.3 TSC2-218
TSC1 and TSC2 (tuberous sclerosis complex 1 and 2) are proteins derived from tsc1 and
tsc2 genes (25) (26). These genes were first identified as tumor suppressor genes (27). Mutations
found in Tsc1 or Tsc2 genes can cause an autosomal dominant disorder known as tuberous
sclerosis (28) (29). This disease state causes various benign tumors (hamartomas) throughout the
body and at times, neurological symptoms (28) (29).
TSC1, also referred to as hamartin (140kDa), and TSC2, as tuberin (200kDa), form a
heterodimer, known as the tuberous sclerosis complex (TSC) (25) (26). TSC is found in many
areas throughout the body including the brain, kidneys, heart, liver, pancreas and other organs
(30).
Studies have shown that the GAP domain at the C-terminal of TSC2 is highly conserved
and homologous to the Rap1GAP (31) and is able to down-regulate Rheb by enhancing its
GTPase activity (28). Specifically, mutations in this TSC2 GAP domain have resulted in a loss
of down-regulation of S6K and 4EBP1 (regulatory proteins activated directly by mTORC1) due
to loss of Rheb GTPase activity (21) (28). Interestingly, the C-terminus mutations did not affect
the interaction of TSC2 with TSC1 and only with Rheb (27). In addition, TSC1 does not seem to
alter GTPase activity of Rheb (32). A smaller 400 residue C-terminal construct of TSC2 is
unable to bind to TSC1, but still activates GTP hydrolysis in Rheb (32). In 2009, Marshall et. al,
used an even smaller truncated version of the C-terminal of TSC2 (TSC2-218) to observe the
GAP stimulated GTPase activity of Rheb using Real-Time NMR (33). This 218 amino acid
truncated version included the GAP domain of TSC2-218 and was still able to maintain GAP
activity towards Rheb as depicted in Figure 2A.
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Figure 2A. Schematic of the interaction between TSC2-218 (truncated construct of TSC2) and
Rheb and the down stream regulation of mTOR pathway. GTP, GDP, Rheb-GTP (1XTS.pdb)
and Rheb-GDP (1XTQ.pdb) structures were obtained through Protein Databank. TSC2-218 WT
was predicted using I-TASSER (35) (36) (37) (38). Schematic was made using PowerPoint.
Though Rheb has been studied extensively, there is relatively very little information
about its interaction mechanism with TSC2 and the structural characteristics of TSC2. In fact,
there is no known full structure of the TSC2 protein. By studying single point mutations in key
regions of TSC2, importance of corresponding residues on TSC2 in interactions with Rheb may
be better understood.
Marshall and colleagues used Real-Time NMR to observe the distinct structural changes
induced by nucleotide dependent conformations to study GTPase activity of Rheb in the
presence of TSC2-218 (a 218 amino acid construct from residues 1525 to 1742) and mutations
(33). In this study, single point mutations were created in residues that were involved in tuberous
sclerosis and residues homologous to Rap1GAP mutations (33).
6

Most mutations in the TSC2-218 GAP catalytic and binding regions showed similar
decrease in GTPase activity as the Rap1GAP homologs, however, there were significant
differences in the adjacent and partially conserved regions (28) (33).
The focus of this project will be to study one such mutation (TSC2-218 D74A) that is
found in the region adjacent to the catalytic core of TSC2. The corresponding mutation showed
an elimination of GAP activity in the homologous RAP1GAP, but not in TSC2 (28) (33). It is
possible that the D74A mutation is able to stabilize the interaction with Rheb (unlike other GAP
mutations in Ras proteins) and maintain GTPase function of Rheb as suggested in Figure 2B.
The truncated 218 amino acid construct of TSC2, TSC2-218, will be used to observe the
characteristics of the TSC2 single point mutation, D74A, and its interaction with Rheb.

Figure 2B. Schematic of the interaction between TSC2-218 D74A (truncated construct of TSC2)
and Rheb and the down stream regulation of mTOR pathway. Rheb-GTP (1XTS.pdb) and RhebGDP (1XTQ.pdb) structures were obtained through Protein Databank. TSC2-218 D74A structure
was predicted using I-TASSER (35) (36) (37) (38). Schematic was made using PowerPoint
II.

Chapter 2: Experimental Methods

2.1 Protein Over-Expression and Purification
2.1.1 Rheb
Ras homology enriched in brain (Rheb) proteins were over-expressed as His6-tagged (6
histidine residues) fusion proteins and purified using affinity chromatography on a Ni2+ column.
Rheb was incorporated into the plasmid vector, pET15b, in the Escherichia coli (E. coli) strain
BL21 (DE3) and over-expressed in LB broth. Glycerol stocks were previously made and used in
7

subsequent over-expression procedures. 1 mL of the pre-existing stocks were added to flasks
containing 100mL of LB broth media and 100uL ampicillin and incubated in the shaker at 37°C
overnight (between 12 to 16 hours). The next morning, the seed cultures were inoculated into 6L
Erlenmeyer flasks containing 1.5L LB broth and 750uL ampicillin and allowed to grow on the
shaker at 37°C. The OD (optical density) was measured using a UV-Vis spectrometer at 600nm
every hour until the culture reached the target OD of 0.6-0.8. Once in this range, the culture was
then induced with 0.5mM IPTG and kept in the shaker at 37°C for four hours. To harvest the
cells containing our target protein, each flask was centrifuged at 6,500 rpm for 20min at 4°C.
The supernatant was discarded and the pellet was collected and resuspended in 10mM Tris pH 6.
The resuspended pellet was then centrifuged at 5,000 rpm for 12-15min at 4°C. The supernatant
was discarded and the pellet was stored in -80°C until purification.
Before purification, the pellet was thawed on ice and then resuspended in lysis buffer
containing 45mg lysozyme, 150uL halt protease, 1mM PMSF and DNAse. The cells were
sonicated on ice for 10 seconds on followed by 10 seconds of rest for a total of 20 minutes. The
lysed sample was then centrifuged for 20min at 18,500 rpm at 4°C. The supernatant was
collected and subsequently filtered. The sample was then loaded into an FPLC (Fast protein
liquid chromatography) machine and purified using affinity chromatography protocols for His6tagged proteins using a 5ml pre-packed Ni2+ column.
PBS Ni2+ binding buffer (PBS pH 8.0, 25mM imidazole and 50mM MgCl2) and PBS
Ni2+ elution (PBS pH 8.0, 400M imidazole and 50mM MgCl2) were made and filtered prior to
purification. The 5ml pre-packed Ni2+ column was stripped of any residual particles and
regenerated with buffers containing nickel. The FPLC machine was washed with autoclaved and
filtered water, binding buffer and elution buffer, and the column (attached to the FPLC) was
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equilibrated with binding buffer. The protein sample and binding buffer were loaded onto the
Ni2+ column. The proteins lacking His6-tag would flow through the column and the target Rheb
protein (His6-tag fusion protein) would bind to the column. Then, increasing amounts of elution
buffer were loaded on the column and at approximately 245-250mM imidazole concentration,
Rheb would elute. Rheb samples were collected in fractions according to the presence of peaks
on the chromatogram. The fractions were collected and band size and purity were confirmed
using SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis). The band size
was confirmed against a molecular weight ladder and purity was established by lack of
appearance of other bands on the gel (Figure 3), the protein sample was dialyzed in Tris pH 8.0
at 4°C overnight (12-16 hours).
If the experiment required Rheb to be active, but unable to undergo intrinsic GTPase
hydrolysis, then the sample was subjected to nucleotide exchange in which a nonhydrolyzable
GTP analog (GMPPNP) was attached. In this procedure, Rheb was incubated for 1 hour at 4°C
with 5mM GTP analog and 5mM EDTA. A desalting column (PD-10) was equilibrated with 5
column volumes of Tris buffer prior to loading the protein sample. Fraction were collected and
tested with Bradford assay reagent to determine the presence of proteins. The target fractions
were then collected combined and 10mM MgCl2 was added. Purified, and if required, nucleotide
exchanged, Rheb protein samples were either immediately stored in -80°C freezer or lyophilized
prior to storage (for longer term storage).
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Figure 3. SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) of a sample
purification of His6-tagged fusion protein, Rheb. The lysate contains all proteins expressed in E.
coli cell, the flow through contains all proteins that do not bind to Nickel column. When loaded
on the column, target His6-tagged protein, Rheb, will bind and at imidazole concentration of
about 250mM, Rheb starts to elute. The fractions containing Rheb are collected. This gel
confirms the size of the protein to be around 20 kDa which corresponds to the molecular weight
of Rheb. In addition, there is a lack of additional bands seen in the gel which confirms the
relative purity of the purified protein sample.
2.1.2 TSC2-218 (WT)
Tuberous sclerosis complex 2 construct with 218 amino acids (TSC2-218) proteins were
GST-tagged fusion protein (contain glutathione-S-transferase tag at the N-terminus), overexpressed and purified using affinity chromatography on a GST affinity column. GST-TSC2-218
was incorporated into the plasmid vector, pET15b, in the Escherichia coli (E. coli) strain BL21
(DE3) and over-expressed in LB broth. Glycerol stocks were previously made and used in
subsequent growth/harvesting procedures similar to that of the Rheb listed above. Unlike for
Rheb, TSC2-218 proteins were allowed to grow until reaching an OD600 of 0.9-1.0 before
induction by 0.5mM IPTG, followed by 4.5 to 5 hours incubation in 37°C. Cells were harvested
similarly to Rheb by centrifugation at 6,500rm for 20min at 4°C and the pellet was resuspended
in 10mM Tris pH 6. The resuspended pellet was then centrifuged at 5,000 rpm for 12-15min at
4°C and stored in -80°C until purification.
10

Before purification, the pellet was thawed on ice and then resuspended in lysis buffer
containing 45mg lysozyme, 150uL halt protease, 75ul PMSF and DNAse. The cells were
sonicated, centrifuged and filtered in a similar fashion to Rheb. The sample was then loaded into
an FPLC (Fast protein liquid chromatography) machine and purified using affinity
chromatography protocols for GST-tagged proteins using a 5ml pre-packed GST affinity column.
Binding buffer containing 10mM PBS pH 7.4 and elution buffer containing 0.02mM Tris
HCL and 10mM glutathione pH 8.0 (freshly prepared before each purification) were made and
filtered prior to purification. The 5ml pre-packed GST affinity column was stripped using 6M
guanidine hydrochloride, washed with water, regenerated with two rounds of 30-50ml of buffers
1 (01M Tris and 0.5 M NaCl pH 8.5) and 2 (0.1 M sodium acetate and 0.5 M NaCl pH 4.5), and
washed again with water. The FPLC machine lines were washed with water, binding and elution
buffer, and the GST affinity column was equilibrated with binding buffer. The protein sample
and binding buffer was loaded onto the GST affinity column where the GST tagged fusion
protein (TSC2-218) would bind to the column (containing glutathione) and other proteins would
flow through the column. When elution buffer prepared with 10mM glutathione, the protein
would elute out in fractions that were then collected to be confirmed using SDS-PAGE (Figure
4A). The sample was then dialyzed in PBS pH 7.4 at 4°C overnight (12-16 hours).
The next day, GST-tagged fusion protein, TSC2-218, underwent thrombin cleavage to
cleave the GST tag (large, around 26kDa) from the protein. One unit of thrombin was added for
every 100µg of protein and incubated for 1-2 hours at 4°C. About 75µl Halt protease inhibitor
cocktail was then added to the mixture and the sample underwent a subsequent purification in
order to remove GST from the protein sample. This purification is similar in procedure, however,
the free GST binds to the column and the unbound/properly cleaved target protein (TSC2-218)
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flows through the column and is collected in fractions. The samples are then checked via SDSPAGE (Figure 4B) and dialyzed using PBS buffer pH 7.4 then subsequently stored at -80°C.

A

B

Figure 4. SDS-PAGE gels of GST-TSC2-218 samples from the GST-fusion protein purification
(A) and subsequent TSC2-218, target protein, purification (B). (A) Lane 1 contains molecular
weight ladder, Lysate contains all proteins expressed by cell, Flow through contains proteins
lacking the GST affinity tag. GST-TSC2-218 elutes with addition of Elution buffer (Glutathione
concentration of 10mM) and fractions containing protein was collected (Protein Collections). (B)
Cleaved protein includes all proteins after thrombin cleavage. Target TSC2-218 protein flows
through the column and is collected. With the addition of elution buffer containing 10mM
glutathione, GST elutes. Bands are checked on SDS-gel for size and purity.
2.1.3 TSC2-218 (D74A)
The procedure for the variant of TSC2-218, D74A, was almost identical to the wild-type.
However, since there were no glycerol stocks of the variant available, plasmids for TSC2-218
(D74A) were acquired and transformed with E. coli NEB 5-alpha strain for plasmid
amplification. After transformation, the cells were plated in LB agar and allowed to grow
overnight at 37°C. Plasmids were isolated from the culture and sequenced (at UAMS DNA
Sequencing Laboratory in Department of Microbiology and Immunology) to check for correct
genetic sequence. After confirmation the sequencing, plasmids were then transformed into E.
coli BL21 (DE3) cells for over-expression.
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Test expressions were performed on the over-expression of E. coli cells containing GSTTSC2-218 (D74A) to optimize conditions to achieve best yields. Conditions that were
specifically tested were the optimal OD600 range and amount of IPTG to induce cell cultures. 1ml
of glycerol stocks were incubated in the shaker at 37°C in 10mL LB media in a 50m falcon tube
with 10uL ampicillin overnight (12-16 hours). The next day, the 10ml cultures were added to a
500ml Erlenmeyer flask containing 90ml LB media, 100uL ampicillin and incubated in the
shaker at 37°C. OD600 (optical density at 600nm) readings were taken on the UV-Vis
spectrometer every 15 min and recorded. Using Excel, the data was converted into a graph
(Figure 5). The mid log phase was determined to be at around OD600 = 0.8-1.0. This was
determined to be the optimal OD range (which was similar to the wild-type).
To confirm the proper absorbance and determine the optimal concentration of IPTG
needed to induce higher yield of protein, 1 ml was taken from each sample at OD = 0.4, 0.6, 0.8
and 1.0 and incubated with 0.5mM and 1.0mM IPTG and incubated in the shaker at 37°C for 4
hours. Each 1ml sample was prepared for SDS-PAGE by being centrifuged at 13,000 rpm for 3
minutes, the supernatant was removed, 15uL of 2X sample dye was added and the sample was
heated for 5 minutes at 80°C. After 4 hours, another 1mL of each sample was placed into a 2ml
centrifuge tube and the steps for sample preparation were repeated. The pre-induction, post
induction and molecular ladder samples were all loaded onto a 15% polyacrylamide gels and
SDS-PAGE was performed (Figure 6A). Band intensities were quantified using densitometry
analysis using UN-SCAN- IT. As represented in Figure 6B, the values were then graphed using
Excel. It was determined that the optimal OD range was around 1.00 and the 1mM IPTG was
only yielded slightly higher band intensity than the 0.5mM so 0.5mM IPTG was used in
subsequent inductions.
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Figure 5: Test expression for optimal optical density range (A600nm). An absorbance was
measured every 15 minutes after inoculation. The data was then recorded and graphically
presented with the use of Excel. The test expression was performed in triplicate.
Lane 1: MW Ladder
Lane 2: OD 0.4 - Pre-Induction
Lane 3: OD 0.4 - 0.5M IPTG
Lane 4: OD 0.4 - 1.0M IPTG
Lane 5: OD 0.6 - Pre-Induction
Lane 6: OD 0.6 - 0.5M IPTG
Lane 7: OD 0.6 - 1.0M IPTG
Lane 8: OD 0.8 - Pre-Induction
Lane 9: OD 0.8 - 0.5M IPTG
Lane 10: OD 0.8 - 1.0M IPTG
Lane 11: OD 1.0 - Pre-Induction
Lane 12: OD 1.0 - 0.5M IPTG
Lane 13: OD 1.0 - 1.0M IPTG
Figure 6A. Test expression for optimal OD and IPTG amount. Pre-induction and post-induction
samples were collected, centrifuged, resuspended in sample dye and loaded onto a 15%
polyacrylamide gel.
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Figure 6B: Graphical representation of densitometric analysis of test expression for optimal
optical density and IPTG concentration. Excel was employed to create this graph.
2.2 Characterization Studies of TSC2-218 (WT) and TSC2-218 (D74A)
2.2.1 Circular Dichroism Spectra
JASCO Corp., J-1500 Spectrometer was used to take circular dichroism measurements
of purified protein samples of TSC2-218 (WT and D74A) in the far-UV range (190-250nm)
using a 2mm pathlength Starna Cells quartz cuvette (Catalog Number: 3-Q-10). The protein
concentration of the samples was diluted to 0.2mg/ml in 10mM phosphate buffer pH of 7.4). The
spectra were measured at 50nm/min for each sample. A spectrum of a cell containing only buffer
was recorded and subtracted from each sample measurement using Excel. Graphs of CD spectra
measurements were obtained using Spectra Manager.
2.2.2 Urea Denaturation
Urea denaturation experiments were carried out using the JASCO Corp., J-1500
Spectrometer in 300nm to 400nm range using 10mm pathlength Starna Cells quartz cuvette
(Catalog Number: 9-Q-10). The purified samples of TSC2-218 (WT and D74A) were diluted to
0.2mg/ml in 10mM phosphate buffer pH of 7.4. A total of 14 spectra were recorded over an
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increasing concentration of 8 Molar (M) urea in autoclaved and filtered water. Urea was titrated
using the Automatic Titration Scan measurement program from a range of 0M to 6.4M urea at
25°C. A baseline buffer spectrum was subtracted from each spectrum using Excel and this
experiment was 2-3 times for each construct of TSC2-218.
To determine the ratio of unfolded protein (Fd) vs concentration of urea, the following
equation (Equation 1) was used where Fi, Ff and F represent initial (native state) intensity, final
intensity and intensity at each point of urea denaturation (34).
Fd =

(F − Fi )
(Ff − Fi )

(Eq. 1)

2.2.3 Thermal Denaturation
Thermal denaturation studies were carried out using JASCO Corp., J-1500 Spectrometer
in the far UV CD (190nm-250nm) using 10nm pathlength Starna Cells quartz cuvette (Catalog
Number: 3-Q-10). The purified samples of TSC2-218 (wild type and D74A) were diluted to
0.28mg/ml in 10mM phosphate buffer pH of 7.4. A total of 14 spectra were recorded with
increasing temperature from 25°C to 90°C. A baseline buffer spectrum was subtracted from each
spectral value using Excel. This experiment was performed with 2-3 samples each and the data
averaged for both TSC2-218 wild type and variant (D74A) samples. Excel was employed to
calculate the ratio of unfolded protein versus temperature for each of the samples and graphically
presented.
2.3 Interaction Studies between RHEB and TSC2-218 (WT and D74A)
2.3.1 Circular Dichroism Difference Spectra
CD difference spectra measurements were also performed using JASCO Corp., J-1500
Spectrometer in the far-UV CD range (190-250nm). The purified protein (Rheb) and effector
protein (TSC2-218) samples were diluted to concentrations of 0.2mg/ml in 10mM phosphate
16

buffer pH of 7.4, to maintain a ratio of 1:1. CD measurements of each sample were taken prior to
incubation. Protein and ligand samples were then incubated together for 30 min at 4°C and CD
measurements were gathered at 0 min and 30 min after incubation. The spectra were measured at
50nm/min for each sample. A buffer spectrum was collected and subtracted from each sample
spectra using Excel. TSC2-218 spectra were then subtracted from the mixture spectra using
Excel and graphs of difference spectra were obtained using Spectra Manager and Excel.
2.3.2 GTPase Hydrolysis Assay
GTP hydrolysis assays were carried out using GTPase-Glo Assay Kit (Promega V7681)
and white 384 Well Polystyrene Microplates (Greiner Bio-One Catalog # 781075) in order to
observe differences in GTPase Activity in Rheb in the presence and absence of TSC2-218 (WT
and D74A). After purification of the Ras GTPase (Rheb), nucleotide exchange with the
nonhydrolyzable GTP analog was not performed. All samples of Rheb and its GAP effectors,
TSC2-218 (WT and D74A), were dialyzed in PBS (pH 7.4) and samples were run on the gel to
confirm the presence of protein prior to performing experiments. The protein samples were
diluted in GTPase/GAP buffer (provided in kit) and luminescence was recorded using the
BioTek Gen5 program and Synergy H1 Hybrid plate reader. The relationship between GTP
concentration and luminescence is provided in Figure 7, where luminescence represents the GTP
concentration.
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Figure 7. Schematic of Promega GTPase Activity Assay describing the procedure summary of
GTPase reaction, incubation, and addition of Reagent 1 (GTPase-Glo Reagent) and Reagent 2
(Detection Reagent).
To observe Rheb’s intrinsic GTP hydrolysis activity, 5uL of Rheb (at various
concentrations from 0uM to 4uM) and 1mM DTT was incubated for 90min at room temperature
with 5uL of 10uM GTP (in GAP buffer). Then, 10uL of reconstituted Glo-GTPase Reagent
(freshly made 15 min prior to use) was added to each reaction and incubated shaking at room
temperature for 30min. Then, 20uL of detection reagent (provided in kit) was added to each well
and incubated at room temperature for 5-10min and luminescence was recorded using Gen5
program on the plate reader. The data was then exported to Excel and Origin and graphically
presented
Once the variables were optimized in multiple test experiments, GTPase Activity Assay
was performed on 10µM Rheb (with 10mM Mg added) in the presence and absence of 2.25µM
TSC2-218 WT and D74A in the following method, where Solutions 1 and 2 were prepared
separately for each sample and then added to the wells to initiate the reaction (Table 2).
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Table 2. Contents of the solution for each variable in the GTPase activity assay. Solution one
was added to the wells first and then solution 2 was added to start the GTPase reaction.
Solution 1
Solution 2
GTP Only

1mM DTT in GTPase/GAP
buffer

10uM GTP in GTPase/GAP buffer

Rheb Only

10uM Rheb and 1mM DTT

10uM GTP in GTPase/GAP buffer

10uM Rheb and 1mM DTT in
Rheb + WT GTPase/GAP buffer

2.25uM TSC2-218 (WT) and 10uM
GTP in GTPase/GAP buffer

Rheb +
D74A

2.25uM TSC2-218 (WT) and 10uM
GTP in GTPase/GAP buffer

10uM Rheb and 1mM DTT in
GTPase/GAP buffer

GAP concentration dependent studies were also performed using TSC2-218 (WT and
D74A) concentrations from 0uM to 2.1uM in the presence of 10uM Rheb. The 0uM TSC2-218
group represented the Rheb control group as it included only Rheb, GTP and all other buffers
(and no GAP protein). A 10uM GTP only group was also tested and this luminescence value was
used to represent the total GTP concentration in the solution. This experiment was repeated 2-4
times for each sample.
III.

Chapter 3: Results

3.1 Characterization Studies of TSC2-218 (WT) and TSC2-218 (D74A)
3.1.1 Circular Dichroism Spectra
To observe the characteristic differences between TSC2-218 Wild-type and variant
(D74A), experiments focusing on the structural, chemical and physical properties were
performed.
The secondary structural differences were compared by performing circular dichroism
studies on TSC2-218 wild-type and variant (D74A). The CD spectra for the variant of TSC2218, D74A, is similar to that of wild-type (WT) (Figure 8). Specifically, there are noticeable
negative peaks at approximately 208 and 223nm which correspond to those of standard alpha
helix spectra (208 and 222nm).
19

Figure 8: Circular Dichroism (CD) Spectra of TSC2-218 Wild Type (WT) and variant (D74A).
Jasco Spectral Management was used to obtain CD spectra data and Excel was used to
graphically present the molar ellipticity data for TSC2-218 wild-type and variant.
3.1.2 Urea Denaturation
To assess the protein stability of the TSC2-218 (D74A) in comparison to wild-type, urea
denaturation experiments were performed. The presence of urea, a chemical denaturant, disrupts
hydrogen bonding (found in secondary and tertiary structure of proteins) and in turn induces the
protein to unravel. Thus, by increasing urea concentrations, the protein begins to unfold. This
unfolding causes any hydrophobic tryptophan residues (intrinsic fluorophore) to be exposed
which in turn show an increase in fluorescence intensity. TSC2-218 contains 2 tryptophan
residues that act as intrinsic fluorophores. With increasing amounts of 8M urea being titrated into
the protein samples, both TSC2-218 wild type and variant started to unfold. A raw data of the
fluorescence spectra at 0M urea and 6.6M urea show a decrease in fluorescence, in addition to a
shift from emission max at approximately 338-340nm to 348nm, respectively (Figure 9A).
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Looking at Figure 9B (fraction denatured over urea concentration), initially (at low urea
concentrations) the amount of unfolded protein of both WT and D74A slowly increases, then the
protein sample contains mostly unfolded protein with a urea concentration of around 6.6M.
Comparison of the averaged WT with the averaged values for the variant (D74A) shows an
almost identical graph of protein unfolding (Figure 9B). However, since the urea denaturation
plot does not seem to be completely denatured, the Y value from the fitted line in Figure 9B was
used as the Ff value for Equation 1. All Fd values were re-adjusted to represent a more accurate
fraction denatured versus urea concentration plot (Figure 9C). Cm values (the urea concentration
at which half the protein is in an unfolded state and half is in the folded state) were calculated
using the adjusted plot. Both TSC2-218 Wild-type and D74A both showed similar values for Cm
(3.47M and 3.58M, respectively).

Figure 9B. Fraction denatured (Fd) plot
of TSC2-218 Wild-Type (WT) and
variant (D74A) against urea
concentration (M) using Equation 1. A
total of 3 different samples were
averaged each for TSC2-218 wild-type
and variant using Excel and graphically
presented above using Origin.

Figure 9A. Fluorescence spectra of TSC2218 at native (0M Urea) and unfolded
(6.6M Urea). There is a distinct decrease in
fluorescence at 6.6M urea and a shift from
max emission intensity at 338nm at native
state and shift towards the right to 348nm
for unfolded protein. Data was graphically
presented on Origin.
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Figure 9C. Urea Denaturation study data representing the adjusted ratio of denatured TSC2-218
WT and variant (D74A) against the urea concentration (M) using Equation 1. Fd values were
adjusted using the fitted value at 10M urea from Figure 9B. Cm values were then derived from
this adjusted plot. 3 different samples were averaged each for TSC2-218 wild-type and variant
using Excel and graphically presented using Origin.
3.1.3 Thermal Denaturation
Thermal denaturation studies can help assess the protein’s thermal stability, indirectly. As
temperature increases, the protein denatures and begins to unfold due to the disruption of
hydrogen bonds forming the secondary structure. As it unfolds, the protein will start to lose its
secondary structure characteristics and can be observed using circular dichroism (CD). A thermal
denaturation study will aid in determining if the protein stability varies due to an addition of a
mutation (TSC2-218 (D74A)). As seen in Figure 10A, as the temperature increases, the fraction
unfolded starts to increase. This represents a decrease in secondary structure. Thus, when looking
at the ratio of folded to unfolded protein, the protein continues to unfold with increasing
temperature until about 85°C when the protein seems to be mostly unfold (Figure 10A).
Comparison of the averaged WT with the averaged values for the variant shows a very similar
graph of protein unfolding (Figure 10A). However, the proteins were not completely
unfolded/denatured. Therefore, the raw data for TSC2-218 WT and D74A spectra was graphed
and fitted using Origin (Figure 10B). The value from the fitted line at temperature of 150°C
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(where the protein is suggested to be completely unfolded/denatured) was used as the Ff value in
Equation 1 in order to adjust the data to a more accurate fraction denatured plot. All measured
values were then adjusted and Fd was plotted against temperature (Figure 10C). The Tm,
temperature at which the Fd value is 0.5 (half unfolded), values for TSC2-218 WT and D74A
were 69.55°C and 70.80°C, respectively.

Figure 10A: Thermal Denaturation study data representing the ratio of denatured TSC2-218
Wild-Type (WT) and variant (D74A) against the temperature (°C) using Equation 1. A total of 23 different samples were averaged each for TSC2-218 wild-type and variant using Excel and
graphically presented using Origin.
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Figure 10B: Raw averaged thermal denaturation data representing the adjusted ratio of denatured
TSC2-218 Wild-Type (WT) and variant (D74A) against the temperature (°C) using Equation 1.
In addition, Fd values were normalized to extrapolated data values at temperatures of 120, 130,
140 and 150°C (obtained from fitted line from Figure 10B). A total of 2-3 different samples were
averaged each for TSC2-218 wild-type and variant using Excel and graphically presented using
Origin.

Figure 10C: Thermal Denaturation study data representing the adjusted ratio of denatured TSC2218 Wild-Type (WT) and variant (D74A) against the temperature (°C) using Equation 1. In
addition, Fd were normalized to extrapolated data values at temperatures of 120, 130, 140 and
150°C (obtained from fitted line from Figure 10B). A total of 2-3 different samples were
averaged each for TSC2-218 wild-type and variant using Excel and graphically presented using
Origin.
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3.2 Interaction Studies between RHEB and TSC2-218 (WT and D74A)
3.2.1 Circular Dichroism Difference Spectra
Circular dichroism (CD) difference spectra were used to observe the changes to the
structure of Rheb in the presence and absence of TSC2-2128 WT and D74A. If binding is
present between two proteins, it can be observed by the change in secondary structure due to a
conformational change upon binding. A CD spectrum was measured for each sample of Rheb
(Blue line) and TSC2-218, WT and D74A (not present), then the proteins were incubated
together and the spectra of the mixture was measured at 0 min and 30 min (Red line). The
spectra of the TSC2-218 (WT and D74A) was mathematically subtracted from the mixture (Rheb
and TSC2-218) to represent the structural characteristic of Rheb after incubation and possible
interaction with TSC2-218 (Orange line). The change in circular dichroism spectra between
Rheb (Blue line) and mathematically determined Rheb (Orange line) represents a conformational
change. In both Figure 11A and Figure 11B, there is a difference in CD Spectra between Rheb
and Corrected Rheb ((Rheb+TSC2-218 Mix spectra) – (TSC2-218 spectra)); therefore, both
TSC2-218 wild-type and variant (D74A) exhibit conformational changes due to binding.
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Figure 11A: Circular dichroism (CD) difference spectral data for Rheb in the presence and
absence of TSC2-218 wild type (WT) was obtained using Jasco Spectra Measurement program.
The data for wavelength vs CD intensity (millidegrees) of Rheb, TSC2-218 WT and Rheb
incubated with TSC2-218 WT for 30min was exported and graphically presented using Excel.
CD data for WT was then mathematically subtracted from incubated Rheb + TSC2-218 WT
mixture to represent the Corrected Rheb CD spectra.

Figure 11B: Circular dichroism (CD) difference spectral data for Rheb in the presence and
absence of TSC2-218 variant (D74A) was obtained using Jasco Spectra Measurement program.
The data for wavelength vs CD intensity (millidegrees) of Rheb, TSC2-218 (D74A) and Rheb
incubated with TSC2-218 (D74A) for 30min was exported and graphically presented using
Excel. Corrected Rheb CD spectra was obtained similarly to the Rheb + WT sample.
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3.2.2 GTPase Hydrolysis Assay
Intrinsic GTPase activity assays are performed to observe a protein’s ability to undergo
hydrolysis of GTP to GDP without the aid of any effectors. To determine the extent of intrinsic
Rheb GTPase activity, various concentrations of Rheb was incubated with 10uM GTP (without
any TSC2-218 GAP proteins) for 90 min and luminescence was measured. According to Figure
12, as the concentration of Rheb increased, the luminescence decreased. However, there was
very little difference between luminescence (which corresponds to the GTP concentration) at
4uM and 0uM Rheb (Figure12).

Figure 12. Graphical representation of intrinsic Rheb GTPase activity. Luminescence
corresponds to the GTP concentration. Data was obtained using the Gen 5 program from BioTek
and exported to Excel. The data was then plotted and fitted using Origin.
TSC2-218 WT and variant (D74A) were incubated with Rheb and GTP for 90min and
then the luminescence was measured in order to observe the GAP effect of TSC2-218 WT and
D74A on GTPase activity of Rheb. Figure 13 depicts that both Rheb + TSC2-218 WT group and
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Rheb + TSC2-218 D74A group had lower GTP concentration than Rheb and GTP only. In
addition, Rheb + D74A group showed a slightly lower GTP concentration than Rheb + WT
(Figure 13).

Figure 13. Graphical representation of GAP (TSC2-218 WT and D74A) stimulated Rheb
GTPase activity. GTP only and Rheb only were used as controls. Data was obtained using the
Gen 5 program from BioTek and exported to Excel. The data was then plotted and fitted using
Origin.
To observe the effect of TSC2-218 WT and D74A concentration on GTPase activity of
Rheb, increasing concentrations of TSC2-218 WT and variant (D74A) were incubated with Rheb
and GTP for 90min and then the luminescence was measured. Figure 14 depicts that with
increasing wild-type TSC2-218 and D74A concentration, GTP concentration was lowered. In
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addition, the WT and variant GAP proteins displayed very little difference between relative GTP
concentrations at each concentration (Figure 14).

Figure 14. Graphical representation of GAP concentration-dependent study of Rheb GTPase
activity in the presence of WT and variant, D74A. GTP only was used to normalize the
luminescence data for all samples. Data was obtained using the Gen 5 program from BioTek and
exported to Excel. The data was then plotted and fitted using Origin.
IV.

Chapter 4: Conclusions and Future Directions
Ras superfamily GTPases are vital in regulating cell signaling and homeostasis. Rheb, the

model Ras GTPase protein studied, signals the activation of the mTOR pathway that further
activates cell division and growth. Due to its low intrinsic GTPase activity of Rheb, TSC2, a
GAP protein, is needed to enhance Rheb GTP hydrolysis. Mutations in key residues in Rheb and
TSC2 have been shown to disrupt the binding to, stability of, and/or enzyme activity of Rheb,
leading to over stimulation of the mTOR pathway. In addition, the molecular details of the TSC2
interaction with Rheb are not completely understood. Therefore, a more comprehensive
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investigation of the effect of single point mutations in residues of TSC2 that are homologous to
key Ran1GAP residues, may shed more light on the Rheb-TSC2 interactions. This project
focused on the single point mutation, D74A, in the region adjacent to the GAP catalytic region of
TSC2 to examine the stabilization and binding effect of this reside on Rheb and TSC2. The
homologous residue in Ran1GAP showed a decrease in GAP activity and resulted in downregulation of GTPase activity in Ran1GTPase. Since this was not observed in TSC2, it was
hypothesized that D74A could lead to stability of the TSC2-Rheb interaction and induce a more
stable binding. Several experiments were performed to observe the structural stability of D74A,
as well as, the interaction Rheb.
4.1 Characterization Studies of TSC2-218 (WT) and TSC2-218 (D74A)
According to the circular dichroism spectra, the mutation D74A showed comparable
secondary structure, specifically alpha-helices, compared to the wild-type. Therefore, the single
point mutation from aspartic acid to alanine helped in maintaining the protein in primarily an
alpha helical form with minimal alternations to secondary structure.
Stability experiments were performed to observe any effect to the protein stability in the
presence of chemical (urea) and thermal denaturants. The urea denaturation studies showed
minimal difference in Cm between wild type (3.47M urea) and mutant (3.58M urea). The low
difference of 0.11M urea between the wild type and variant suggests that the single point
mutation does not disrupt the stability of the protein in the presence of a chemical denaturant
(urea).
Thermal denaturation studies were performed to confirm the effect of the single mutation
to the protein stability by increasing the temperature of the protein sample. According to the data
derived from thermal denaturation studies, there is very little difference between the Tm values
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for wild type (69.55°C) and D74A (70.80°C). This corresponds with the findings from the urea
denaturation studies in that the single point mutation does not affect the stability of the protein.
Ultimately, the variant seems to have minimal effect on the secondary structure
(primarily that of alpha helices) and the chemical and thermal protein stability of TSC2-218
overall, remained quite stable (maybe even slightly more stable) compared to that of the WT.
4.2 Interaction Studies between RHEB and TSC2-218 (WT and D74A)
The circular dichroism (CD) difference spectra showed that there was difference between
the Rheb spectra and the mathematically calculated spectra of TSC2-218 mixture - TSC2-218 for
both the TSC2-218 WT and D74A samples. This finding implicates that there is binding between
the variant, D74A, and Rheb as the difference in spectra is caused by the conformational change
upon TSC2-218 and Rheb due to binding.
The GTPase activity assay of Rheb in the presence of only 10uM GTP, suggested little
difference in luminescence (which corresponds to GTP concentration) between high (4uM) and
low (0uM) concentrations of Rheb (Figure 12). This data confirms the previous findings that the
intrinsic GTPase properties of Rheb were very low.
When Rheb was incubated with TSC2-218 WT and D74A, both GAP proteins showed a
distinct decrease in GTP concentration in comparison to Rheb only group and GTP only group
(Figure 13). In addition, there was no large difference between the WT and variant TSC2-218
samples, which confirms that the single point mutation does not diminish its GAP activity
towards Rheb and thus, Rheb GTPase activity is maintained. Further, in the TSC2-218
concentration dependent GTPase activity study, it was confirmed that TSC2-218 wild-type and
D74A both enhanced GTP hydrolysis in Rheb and there was little difference between the WT

31

and variant in GAP activity. However, the assay would have to be performed with higher
concentrations of TSC-218 in order to significantly confirm presence of any differences.
Characterization studies of the interaction between Rheb and TSC2-218 (D74A) have
shown that the mutation does not seem to diminish the overall ability to bind to Rheb (seen by
the maintained difference in difference CD spectra) or GAP activity towards Rheb.
4.3 Future Directions
In conclusion, this project has detailed preliminary information of TSC2-218 (D74A) in
terms of stability, secondary structure, GAP stimulated Rheb GTPase activity and qualitative
binding interactions with Rheb. This information can also be used to draw conclusions on overall
interactions between Rheb-TSC2. In addition, it is an unique TS2 residue that is able to stabilize
the interaction with Rheb in comparison to similar mutations in homologous GAP proteins.
However, more work needs to be done to understand the molecular details of Rheb-TSC2
binding.
Since there is limited information on the structure of TSC2, it would be interesting to
study TSC2 WT and variants using NMR (nuclear magnetic resonance) and/or X-Ray
crystallography. Though previous attempts have been made to employ NMR to study TSC2,
obstacles, such as the propensity of TSC2 to aggregate at high concentrations (necessary for
NMR), have made it difficult to obtain viable data (39). Further attempts need to be made to
optimize conditions to enable NMR characterization. Alternatively, X-Ray crystallography can
also be used to derive structural information on wild-type and variant TSC2.
Further, one of the main goals of studying D74A single mutation is to observe binding
with Rheb. Since GAP activity is maintained in the variant, it is important to examine the
binding capacity of D74A in relation to wild-type. This can be done by performing in-vitro
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binding assays and isothermal titration calorimetry (ITC). In-vitro binding can be performed
using affinity chromatography and SDS-PAGE and provides qualitative information about
TSC2-Rheb binding. In contrast, ITC provides quantitative thermodynamic binding data.
A more comprehensive study of TSC2, wild-type and variant, and molecular details of its
interaction with Rheb is vital to understanding specific role of D74A in TSC2 and why it does
not follow the trend of its Ran1GAP homolog. In addition, these findings will also aid in
shedding light on the specific key residues and general interaction of TSC2 and Rheb. These
results can also be applied to Ras proteins and their effectors as a whole. Furthermore,
conclusions from these studies may be used to optimize drug treatments for tuberous sclerosis
diseases by shedding light on possible targeting sites.
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